Basal Insulin Secretion Capacity Predicts the Initial Response and Maximum Levels of Beta‐hydroxybutyrate During Therapy with the Sodium‐glucose Co‐transporter‐2 Inhibitor Tofogliflozin, in Relation to Weight Loss
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism(2019)
Abstract
To investigate predictors of the initial response of beta‐hydroxybutyrate (BHB) and maximum BHB (max‐BHB) values during long‐term therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin (TOFO), and to explore the association of the initial elevation of BHB with subsequent clinical effects in people with type 2 diabetes mellitus.
MoreTranslated text
Key words
beta-hydroxybutyrate,free fatty acid,insulin secretion,sodium-glucose co-transporter-2 inhibitor,tofogliflozin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined